XML 37 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Summary of Financial Instruments Measured at Fair Value on Recurring Basis
The following tables set forth the Company’s financial assets and liabilities that were measured at fair value on a recurring basis as of the dates indicated by level within the fair value hierarchy (in thousands):
September 30, 2022
Level 1Level 2Level 3Total
Assets
Unrestricted cash equivalents and investments(1)
Money market funds$1,885 $— $— $1,885 
Certificates of deposit— 429,359 — 429,359 
Commercial paper— 1,083,272 — 1,083,272 
Corporate bonds— 85,146 — 85,146 
U.S. government securities— 39,716 — 39,716 
Total unrestricted cash equivalents and short-term investments1,885 1,637,493 — 1,639,378 
Restricted cash equivalents and investments(2)
Money market funds91,231 — — 91,231 
Certificates of deposit— 269,287 — 269,287 
Commercial paper— 659,193 — 659,193 
Corporate bonds— 29,007 — 29,007 
U.S. government securities— 63,340 — 63,340 
Total restricted cash equivalents and investments91,231 1,020,827 — 1,112,058 
Marketable equity securities(3)
4,919 — — 4,919 
Total financial assets$98,035 $2,658,320 $— $2,756,355 
Liabilities
Contingent consideration(4)
$— $— $15,000 $15,000 
Total financial liabilities$— $— $15,000 $15,000 
_______________
(1)$72.8 million of cash, $51.3 million of money market deposit accounts and $15.0 million of term deposits are not subject to recurring fair value measurement and therefore excluded from this table. However, these balances are included within the $1.8 billion of cash and cash equivalents and short-term investments on the condensed consolidated balance sheets.
(2)$56.1 million of restricted cash and $5.0 million of a restricted term deposit are not subject to recurring fair value measurement and therefore excluded from this table. However, these balances are included within the $1.2 billion of restricted cash and cash equivalents and restricted short-term investments on the condensed consolidated balance sheets.
(3)Included in other investments on the condensed consolidated balance sheets.
(4)In the second quarter of 2022, the Company completed the acquisition of PBSC which included up to $15.0 million in contingent consideration to be paid over the next year. The contingent consideration was classified as a liability and included in accrued and other current liabilities on the condensed consolidated balance sheets. Refer to Note 3 "Acquisitions" to the condensed consolidated financial statements for information regarding this contingent consideration.
December 31, 2021
Level 1Level 2Level 3Total
Unrestricted Balances(1)
Money market funds$22,250 $— $— $22,250 
Certificates of deposit— 505,438 — 505,438 
Commercial paper— 806,388 — 806,388 
Corporate bonds— 99,705 — 99,705 
Total unrestricted cash equivalents and short-term investments22,250 1,411,531 — 1,433,781 
Restricted Balances(2)
Money market funds20,161 — — 20,161 
Certificates of deposit— 421,144 — 421,144 
Commercial paper— 523,489 — 523,489 
Corporate bonds— 63,458 — 63,458 
U.S. government securities— 31,717 — 31,717 
Total restricted cash equivalents and investments20,161 1,039,808 — 1,059,969 
Total unrestricted and restricted cash equivalents and investments$42,411 $2,451,339 $— $2,493,750 
_______________
(1)$104.8 million of cash, $330.3 million of money market deposit accounts and $385.0 million of term deposits are not subject to recurring fair value measurement and therefore excluded from this table. However, these balances are included within the $2.3 billion of cash and cash equivalents and short-term investments on the condensed consolidated balance sheets.
(2)$53.7 million of restricted cash and $5.0 million of a restricted term deposit are not subject to recurring fair value measurement and therefore excluded from this table. However, these balances are included within the $1.1 billion of restricted cash and cash equivalents and restricted short-term investments on the condensed consolidated balance sheets.
Summary of Reconciliation of Level 3 Financial Assets The following table provides a reconciliation of the beginning balances of the Level 3 financial assets during the nine months ended September 30, 2022 (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Balance at beginning of period$128,086 $64,043 $64,043 $— 
Additions(1)
— — 64,043 64,043 
Change in fair value(2)
(128,086)— (128,086)— 
Balance at end of period$— $64,043 $— $64,043 
_______________
(1)Relates to non-marketable equity securities included in other investments on the condensed consolidated balance sheets.
(2)In the third quarter of 2022, the entire amount of the investment in the non-marketable equity security was impaired due to the announced winding down of the equity investee. The resulting impairment charge was recorded to other income (expense), net on the condensed consolidated statement of operations.
Summary of Reconciliation of Level 3 Financial Liabilities
The following table provides a reconciliation of the beginning balances of the Level 3 financial liabilities during the nine months ended September 30, 2022 (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Balance at beginning of period$14,100 $— $— $— 
Additions(1)
— — 14,100 — 
Change in fair value900 — 900 — 
Balance at end of period$15,000 $— $15,000 $— 
_______________
(1)Relates the contingent consideration from the acquisition of PBSC, which are included in accrued and other current liabilities on the condensed consolidated balance sheets. Refer to Note 3 "Acquisitions" to the condensed consolidated financial statements for information regarding this contingent consideration